Correlation of H-type hypertension and prognosis of ischemic stroke

National Medical Journal of China

Volumn 92, Issue 17, 2012, Pages 1183-1186

  Wang, Hai Li ^a   Tan, Song ^a   Song, Bo ^a   Miao, Wang ^a   Gao, Yuan ^a   Zhao, Lu ^a   Lu, Jia Meng ^a   Xu, Yu Ming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Brain ischemic stroke; Interaction; Prognosis; Stroke

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; H TYPE HYPERTENSION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RANKIN SCALE; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84868699892     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.17.008     Document Type: Article

References (15)

1. Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke, 2008, 39: 1668-1674.
2. Casas J P, Bautista L E, Smeeth L, et al. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet, 2005, 365: 224-232.
3. Xu X, Li J, Sheng W, et al. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis, 2008, 26: 48-62.
4. 2008, 47: 916-911.
5. Graham I M, Daly L E, Refsum H M, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA, 1997, 277: 1775-1781.
6. 2010, 43: 146-153.
7. Sacco R L, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation, 2006, 113: e409-e449.
8. Weisscher N, Vermeulen M, Roos Y B, et al. What should be defined as good outcome in stroke trials: a modified Rankin score of 0-1 or 0-2?. J Neurol, 2008, 255: 867-874.
9. Hankey G J, Eikelboom J W. Homocysteine and stroke. Curr Opin Neurol, 2001, 14: 95-102.
10. Ntaios G, Savopoulos C, Grekas D, et al. The controversial role of B-vitamins in cardiovascular risk: An update. Arch Cardiovasc Dis, 2009, 102: 847-854.
11. Pniewski J, Chodakowska-Zebrowska M, Woźniak R, et al. Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiol Exp (Wars), 2003, 63: 127-130.
12. Newman G C, Bang H, Hussain S I, et al. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology, 2007, 69: 2054-2062.
13. Rolita L, Holtzer R, Wang C, et al. Homocysteine and mobility in older adults. J Am Geriatr Soc, 2010, 58: 545-550.
14. 2008, 88: 3316-3318.
15. Song I U, Kim J S, Ryu S Y, et al. Are plasma homocysteine levels related to neurological severity and functional outcome after ischemic stroke in the Korean population?. J Neurol Sci, 2009, 278: 60-63.